Kevin Lee, Chief Executive Officer at BICYCLE THERAPEUTICS plc (BCYC), sold 24,794 shares at $36.23 ($899K) on 2021-08-31, disclosed to the SEC on 2021-08-31.
Open-market sale of $899k BCYC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.02 | 1,808 | $65K | 7.2% |
| 2 | $36.02 | 1,808 | $65K | 7.2% |
| 3 | $36.23 | 9,953 | $361K | 40.1% |
| 4 | $36.23 | 9,953 | $361K | 40.1% |
| 5 | $37.08 | 1,272 | $47K | 5.2% |
| Total | $36.24 avg | 24,794 |
| $899K |
| 100% |
| Filing → |
| BCYC | SELL | 2026-04-06 | $38K | — | Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |